Quick Asked: Zymeworks Contact Us?
Last update: 16 Apr, 2024 
153 Views
What does zymeworks do? Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage.Is zymeworks available in asia pacific? Zymeworks Announces First Patient with Advanced HER2-Positive Breast Cancer Dosed with Zanidatamab in Combination with Tukysa® (Tucatinib) and Chemotherapy BeiGene rights in Asia Pacific countries including China, South Korea, Australia, and New Zealand but excluding Japan.Where is zonezymeworks inc zym based? Zymeworks Inc. is headquartered in Vancouver, Canada. Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings. Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.How long did the interview process take for you at zymeworks? The process took 3 weeks. I interviewed at Zymeworks (United States) Lasted a few weeks after a lot of back and forth. I almost didn’t continue with interviews because the hiring manager was all over the place and wasn’t good at communication. Several interviews.
Listing Results Zymeworks Contact Us? Question Answers
Zymeworks Inc. in SUITE 2600, THREE BENTALL CENTRE 595
Zymeworks Inc. is a Canada Non-Distributing Corporation With More Than 50 Shareholders filed On September 8, 2003. The company's filing status is listed as Active and its File Number is 6136451.The company's principal address is Suite 2600, Three Bentall Centre 595 Burrard Street, Vancouver, BC V7X 1L3 CA.
Zymeworks Company Profile Office Locations, ...
Zymeworks Names Neil Josephson, M.D., Chief Medical Officer Content Import Tue, 11/09/2021 - 16:08 Zymeworks Names Neil Josephson, M.D., Chief Medical Officer 11/09/2021 at 4:05 PM EST This release is a backfill from a News Wire General ...
Zymeworks Inc Company Profile Vancouver, BC, Canada
Company Description: Zymeworks Inc is located in Vancouver, BC, Canada and is part of the Scientific Research and Development Services Industry. Zymeworks Inc has 425 total employees across all of its locations and generates $38.95 million in sales (USD). There are 3 companies in the Zymeworks Inc corporate family.
Zymeworks Inc. Email Format zymeworks.com Emails
Zymeworks Inc. uses 3 email formats. The most common Zymeworks Inc. email format is first '.' last (ex. jane.doe@ zymeworks.com) being used 50.0% of the time. Other common formats are first (ex. jane@ zymeworks.com) and first_initial last (ex. jdoe@ zymeworks.com) . Get Verified Emails for Zymeworks Inc. Employees.
Zymeworks Crunchbase Company Profile & Funding
Phone Number (604)678-1388 Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. The company is committed to developing best-in-class protein therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases.
Zymeworks Inc. Profile on TNet BC technology
Zymeworks Expands Commercial Team and Creates New R&D Role Vancouver February 10, 2021 Want More Zymeworks Inc. News? 1 2 3 4 5 6 7 8 Next » Twitter Contact Information 540 - 1385 West 8th Avenue Vancouver, BC V6H 3V9 Canada [ MAP ]
Company Zymeworks News, Employees and Funding Information
Zymeworks is a biotherapeutics company that is developing best-in-class Azymetric™ bi-specific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory diseases. The company’s novel Azymetric™, AlbuCORE™, and EFECT™ platforms, and its proprietary ZymeCAD™ structure-guided protein engineering technology, ...
Zymeworks Wikipedia
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding ...
Zymeworks Announces Abstract for Zanidatamab in LateLine
Zymeworks is developing zanidatamab in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for ...
Zymeworks Announces Expansion of Zanidatamab Pivotal Trial
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that its collaborator, BeiGene, Ltd., has dosed the first patient in South Korea in the HERIZON‑GEA‑01 trial.
Zymeworks Biopharmaceuticals Inc. in Seattle, WA Company
Zymeworks Biopharmaceuticals Inc. is a Washington Wa Profit Corporation filed On December 5, 2014. The company's filing status is listed as Active and its File Number is 603457275. The Registered Agent on file for this company is Melissa Alegre and is located at 1215 4th Ave Ste 2100, Seattle, WA 98161.
Home Zymeworks
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Jobs with Zymeworks Inc biospace.com
About Zymeworks Inc. Established in 2003 with offices in Vancouver, BC and Seattle, WA, Zymeworks is a fast-growing, clinical-stage biotechnology company dedicated to the research, development and commercialization of best-in-class therapeutic bispecific antibodies and antibody drug conjugates for the treatment of cancer, autoimmune and inflammatory ...
Zymeworks Inc. (ZYME) Company Profile & Overview Stock
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal
ZYMEWORKS INC. Top 13F Holdings Whalewisdom
(604) 678-1388 Contact Info. zymeworks inc. 540-1385 WEST 8TH AVENUE. VANCOUVER A1 V6H 3V9. Business Phone: (604) 678-1388. SEC SIC CODE: 2834-PHARMACEUTICAL PREPARATIONS.
Alissa Wunder's email & phone number Manager, Office
View Alissa Wunder's email address: wxx@ zymeworks.com & phone: +1-xxx-xxx-5590's profile as Manager, Office Services at Zymeworks Inc., located in Greater Vancouver Metropolitan Area. Find contacts: direct phone number, email address, work experience.
Zymeworks Announces New Multispecific Antibody
In exchange, Zymeworks will receive an undisclosed upfront payment and if each of the three programs yield an approved product, Zymeworks is eligible to receive up to US$411 million in option
Zymeworks Corporate Headquarters, Office Locations and
All Zymeworks Locations. Vancouver (HQ) Canada. 1385 W 8th Ave #540. Seattle, WA. United States. 1215 4th Ave #2100. Report incorrect company information. Location of ...
Working at Zymeworks Glassdoor
Glassdoor gives you an inside look at what it's like to work at Zymeworks, including salaries, reviews, office photos, and more. This is the Zymeworks company profile. All content is posted anonymously by employees working at Zymeworks.
Ali Tehrani's email & phone Zymeworks Inc.'s President
Rocketreach finds email, phone & social media for 450M+ professionals. Try for free at rocketreach.co Ali Tehrani's email & phone Zymeworks Inc.'s ...
ZYMEWORKS INC. : ZYME Stock Price CA98985W1023
Zymeworks Inc. is a clinical-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer. Its lead product candidate is zanidatamab, a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2).
Contact Us Zymeworks
(604) 678-1388 Contact Us Corporate Head Office Zymeworks Inc 1385 West 8th Avenue, Suite 540 Vancouver BC, Canada V6H 3V9 T. (604) 678-1388 F. (604) 737-7077 mapboxgl.accessToken
ZYME Zymeworks Inc. Profile MarketWatch
604 678-1388 Zymeworks Inc. 1385 West 8th Avenue. Suite 540. Vancouver, British Columbia V6H 3V9. Phone 1 604 678-1388. Industry Biotechnology. Sector ...
ZYME Company Profile for ZYMEWORKS INC. MSN Money
Zymeworks Inc. a clinical-stage biopharmaceutical company that is engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada.
Zymeworks Inc. LinkedIn
About us. Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of ...
Zymeworks Inc (ZYMEN) Quote The Globe and Mail
Description. Zymeworks Inc is a clinical-stage company. It is dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on